OSCR · Oscar Health, Inc.
$29.50
-1.27 (-4.13%)
At close · Jul 22
Market Cap
$8.89B
Shares
301.49M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$11.7B
+27.5%
FY2025
Net Income
-$443.15M
-1842.5%
FY2025
Operating Margin
-3.39%
-4pp
FY2025
Diluted EPS
-$1.69
-1790%
FY2025
Operating Cash Flow
$1.09B
+11.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $13.3B | $11.7BG | $9.18B | $5.86B | $3.96B | $1.84B | |
| $13.05B | $11.47B | $8.97B | $5.69B | $3.87B | $1.83B | |
| $29.18M | $28.89M | $32.15M | $339.72M | $309.78M | $265.08M | |
| $2.27B | $2.05B | $1.76B | — | — | — | |
| — | $28.89M | $32.15M | $30.69M | $15.28M | $14.61M | |
| $10.61M | -$396.36M | $57.27M | -$235.62M | -$589.87M | -$544.48M | |
| — | -3.39% | 0.62% | -4.02% | -14.88% | -29.61% | |
| — | -$367.47M | $89.41M | -$204.92M | -$574.58M | -$529.88M | |
| $16.99M | $17.6M | $23.73M | $24.6M | $22.62M | $4.72M | |
| -$20.35M | -$23.34M | -$105K | -$7.08M | — | — | |
| -$74K | — | — | — | -$1.27M | $212K | |
| -$26.74M | -$437.3M | $33.43M | -$267.3M | -$610.08M | -$570.58M | |
| $12.65M | $5.61M | $7.31M | $3.29M | -$523K | $846K | |
| -$39.43M | -$443.15M | $25.43M | -$270.73M | -$606.28M | -$572.61M | |
| — | -3.79% | 0.28% | -4.62% | -15.3% | -31.14% | |
| $40K | $248K | $689K | $134K | -$3.28M | $1.18M | |
| — | -$443.15M | — | — | -$606.28M | -$572.61M | |
| -$44.03M | -$423.29M | $22.3M | -$259.7M | -$612.32M | -$577.16M | |
| USD/shares | — | -$1.69 | $0.11 | -$1.22 | -$2.85 | -$3.20 |
| USD/shares | — | -$1.69 | $0.10 | -$1.22 | -$2.85 | -$3.20 |
| shares | — | 262.39M | 240.39M | 221.66M | 212.47M | 178.97M |
| shares | — | 262.39M | 265.85M | 221.66M | 212.47M | 178.97M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Healthcare Plans median 0.51×
EV/EBIT
—
Healthcare Plans median 18.90×
P/E (TTM)
—
Healthcare Plans median 40.71×
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1568651
CUSIP
687793109
13F (30d)
56 filings
55 filers
Visit website
Investor relations